ArticleScientific reports2017

Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV).

Ashley N Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.